Fatty acid binding proteins shape the cellular response to activation of the glucocorticoid receptor

Glucocorticoids are steroid hormones that are essential for life in mammals. Therapeutically, they are some of the most cost-effective drugs for the treatment of inflammatory diseases ranging from skin rashes to COVID-19, but their use is limited by adverse effects. Glucocorticoids exert their effects via the glucocorticoid receptor, a type I nuclear hormone receptor which modulates gene expression. The transcriptional activity of some related, but nuclear restricted, type II nuclear hormone receptors can be enhanced by a family of intracellular transport proteins, the fatty acid binding proteins (FABPs). We find that the transcriptional activity of the GR can be altered by a sub-set of FABP family members dependent on the GR-ligand. The ability of some FABPs to selectively promote or limit the transcriptional activity of the GR in a ligand-dependent manner could facilitate the discovery of drugs that narrow GR activity to only the desired subset of therapeutically relevant genes. Overall design: Effect of vehicle (DMSO) vs dexamethasone treatment on COS-7 cells transfected with the glucocorticoid receptor and vector control, glucocorticoid receptor and FABP1 or glucocorticoid receptor and FABP4. Samples are from four biological repeats of each condition (n=4).